• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2011 年日本重症监护病房中急性肾损伤的连续性肾脏替代治疗现状:国家行政数据库分析。

Current state of continuous renal replacement therapy for acute kidney injury in Japanese intensive care units in 2011: analysis of a national administrative database.

机构信息

Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, Tokyo, Japan.

Department of Health Economics and Epidemiology Research, School of Public Health, The University of Tokyo, Tokyo, Japan.

出版信息

Nephrol Dial Transplant. 2015 Jun;30(6):988-95. doi: 10.1093/ndt/gfv069. Epub 2015 Mar 19.

DOI:10.1093/ndt/gfv069
PMID:25795153
Abstract

BACKGROUND

Nationwide data for the prevalence and outcomes of patients receiving continuous renal replacement therapy (CRRT) in intensive care units (ICUs) are scarce. This study assessed the status of CRRT in Japanese ICUs using a nationwide administrative claim database.

METHODS

Data were extracted from the Japanese Diagnosis Procedure Combination database for 2011. From a cohort of critically ill patients aged 12 years or older who were admitted to ICUs for 3 days or longer, acute kidney injury (AKI) patients treated with CRRT were identified. The period prevalence of CRRT and in-hospital mortality were calculated. Logistic regression analysis identified factors associated with in-hospital mortality.

RESULTS

Of 165 815 ICU patients, 6478 (3.9%) received CRRT for AKI. The most frequent admission diagnosis category was diseases of the circulatory system (n = 3074). The overall in-hospital mortality rate of the CRRT-treated AKI patients was 50.6%. Clustering patients into four groups by background revealed the lowest in-hospital mortality rate of 41.5% for the cardiovascular surgery group (n = 1043) compared with 53.5% for the nonsurgical cardiovascular group (n = 2031), 51.7% for the sepsis group (n = 1863) and 51.6% for other cases (n = 1541). Multiple logistic regression analysis showed a significant association of these four group classifications with in-hospital mortality in addition to age, hospital characteristics (type and volume), time from hospital admission to CRRT initiation and interventions performed on the day of CRRT initiation.

CONCLUSIONS

Using a large Japanese nationwide database, this study revealed remarkably high in-hospital mortality of CRRT-treated AKI patients, although the period prevalence of CRRT for AKI in ICUs was low.

摘要

背景

关于重症监护病房(ICU)中接受连续肾脏替代治疗(CRRT)的患者的患病率和结局的全国性数据很少。本研究使用全国性行政索赔数据库评估日本 ICU 中 CRRT 的现状。

方法

从 2011 年日本诊断程序组合数据库中提取数据。从入住 ICU 3 天或更长时间的年龄在 12 岁及以上的危重病患者队列中,确定接受 CRRT 治疗的急性肾损伤(AKI)患者。计算 CRRT 的期间患病率和院内死亡率。使用逻辑回归分析确定与院内死亡率相关的因素。

结果

在 165815 名 ICU 患者中,有 6478 名(3.9%)因 AKI 接受 CRRT 治疗。最常见的入院诊断类别是循环系统疾病(n=3074)。接受 CRRT 治疗的 AKI 患者的总体院内死亡率为 50.6%。根据背景将患者分为四组,心血管手术组(n=1043)的院内死亡率最低,为 41.5%,而非手术心血管组(n=2031)为 53.5%,脓毒症组(n=1863)为 51.7%,其他病例(n=1541)为 51.6%。多变量逻辑回归分析显示,除年龄、医院特征(类型和容量)、从入院到开始 CRRT 的时间以及开始 CRRT 当天进行的干预外,这四个分组与院内死亡率显著相关。

结论

使用大型日本全国性数据库,本研究显示 ICU 中接受 CRRT 治疗的 AKI 患者的院内死亡率非常高,尽管 ICU 中 AKI 的 CRRT 期间患病率较低。

相似文献

1
Current state of continuous renal replacement therapy for acute kidney injury in Japanese intensive care units in 2011: analysis of a national administrative database.2011 年日本重症监护病房中急性肾损伤的连续性肾脏替代治疗现状:国家行政数据库分析。
Nephrol Dial Transplant. 2015 Jun;30(6):988-95. doi: 10.1093/ndt/gfv069. Epub 2015 Mar 19.
2
Sepsis may not be a risk factor for mortality in patients with acute kidney injury treated with continuous renal replacement therapy.对于接受持续肾脏替代治疗的急性肾损伤患者,脓毒症可能并非死亡风险因素。
J Crit Care. 2015 Oct;30(5):998-1002. doi: 10.1016/j.jcrc.2015.06.021. Epub 2015 Jun 26.
3
[Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].基于KDIGO分类的早期启动连续性肾脏替代治疗对急性肾损伤危重症患者预后的影响
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Mar;28(3):246-51.
4
Clinical variables associated with poor outcome from sepsis-associated acute kidney injury and the relationship with timing of initiation of renal replacement therapy.与脓毒症相关性急性肾损伤不良预后相关的临床变量及其与开始肾脏替代治疗时机的关系。
J Crit Care. 2017 Aug;40:154-160. doi: 10.1016/j.jcrc.2017.03.022. Epub 2017 Mar 30.
5
Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy.红细胞分布宽度是连续性肾脏替代治疗急性肾损伤患者死亡率的独立预测因子。
Nephrol Dial Transplant. 2012 Feb;27(2):589-94. doi: 10.1093/ndt/gfr307. Epub 2011 Jun 28.
6
Temporal change in characteristics and outcomes of acute kidney injury on renal replacement therapy in intensive care units: analysis of a nationwide administrative database in Japan, 2007-2016.急性肾损伤在重症监护病房行肾脏替代治疗的特征和结局的时间变化:日本全国行政数据库的分析,2007-2016 年。
Crit Care. 2019 May 15;23(1):172. doi: 10.1186/s13054-019-2468-8.
7
Choice of renal replacement therapy modality in intensive care units: data from a Japanese Nationwide Administrative Claim Database.重症监护病房中肾脏替代治疗方式的选择:来自日本全国行政索赔数据库的数据。
J Crit Care. 2015 Apr;30(2):381-5. doi: 10.1016/j.jcrc.2014.11.003. Epub 2014 Nov 13.
8
[Risk factors for mortality in intensive care unit patients with sepsis combined with acute kidney injury after continuous renal replacement therapy: secondary analysis of the data from a multicenter observational study].[连续性肾脏替代治疗后脓毒症合并急性肾损伤的重症监护病房患者的死亡危险因素:一项多中心观察性研究数据的二次分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Feb;31(2):155-159. doi: 10.3760/cma.j.issn.2095-4352.2019.02.007.
9
Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill AKI survivors.初始肾脏替代治疗(RRT)方式与危重症急性肾损伤(AKI)幸存者出院后90天的RRT依赖相关。
J Crit Care. 2024 Aug;82:154764. doi: 10.1016/j.jcrc.2024.154764. Epub 2024 Mar 8.
10
Low-dose continuous renal replacement therapy for acute kidney injury.低剂量连续性肾脏替代疗法治疗急性肾损伤
Int J Artif Organs. 2012 Jul;35(7):525-30. doi: 10.5301/ijao.5000110.

引用本文的文献

1
Hepatic function markers as prognostic factors in patients with acute kidney injury undergoing continuous renal replacement therapy.肝功能标志物作为行连续性肾脏替代治疗的急性肾损伤患者的预后因素。
Ren Fail. 2024 Dec;46(1):2352127. doi: 10.1080/0886022X.2024.2352127. Epub 2024 May 21.
2
Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study.危重症患者连续性肾脏替代治疗期间甲磺酸萘莫司他的剂量:一项两中心观察性研究。
BMC Nephrol. 2024 Feb 26;25(1):69. doi: 10.1186/s12882-024-03506-0.
3
Solute Clearance Evaluation and Filter Clotting Prediction in Continuous Renal Replacement Therapy.
连续性肾脏替代治疗中溶质清除评估与滤器凝血预测
J Clin Med. 2023 Dec 15;12(24):7703. doi: 10.3390/jcm12247703.
4
Elevated mean arterial pressure is associated with a lower risk of mortality in acute kidney injury patients receiving continuous renal replacement therapy.平均动脉压升高与接受连续性肾脏替代治疗的急性肾损伤患者的死亡率降低相关。
Ren Fail. 2023 Dec;45(1):2238828. doi: 10.1080/0886022X.2023.2238828.
5
Association of Hyperkalemia and Hypokalemia with Patient Characteristics and Clinical Outcomes in Japanese Hemodialysis (HD) Patients.日本血液透析(HD)患者高钾血症和低钾血症与患者特征及临床结局的关联
J Clin Med. 2023 Mar 8;12(6):2115. doi: 10.3390/jcm12062115.
6
Hyperlactatemia is a predictor of mortality in patients undergoing continuous renal replacement therapy for acute kidney injury.高乳酸血症是急性肾损伤行连续性肾脏替代治疗患者死亡的预测因子。
BMC Nephrol. 2023 Jan 14;24(1):11. doi: 10.1186/s12882-023-03063-y.
7
Overview of Renal Replacement Therapy Use in a General Intensive Care Unit.普通重症监护病房中肾脏替代治疗的使用概述。
Int J Environ Res Public Health. 2022 Feb 21;19(4):2453. doi: 10.3390/ijerph19042453.
8
A Review on the Application and Limitations of Administrative Health Care Data for the Study of Acute Kidney Injury Epidemiology and Outcomes in Children.行政医疗保健数据在儿童急性肾损伤流行病学及预后研究中的应用与局限性综述
Front Pediatr. 2021 Oct 27;9:742888. doi: 10.3389/fped.2021.742888. eCollection 2021.
9
Surviving Sepsis Campaign: Research Opportunities for Infection and Blood Purification Therapies.拯救脓毒症运动:感染与血液净化疗法的研究机遇
Crit Care Explor. 2021 Sep 7;3(9):e0511. doi: 10.1097/CCE.0000000000000511. eCollection 2021 Sep.
10
Net ultrafiltration rate and its impact on mortality in patients with acute kidney injury receiving continuous renal replacement therapy.接受连续性肾脏替代治疗的急性肾损伤患者的净超滤率及其对死亡率的影响。
Clin Kidney J. 2019 Dec 17;14(2):564-569. doi: 10.1093/ckj/sfz179. eCollection 2021 Feb.